Cristin-person-ID: 521592
Person

Axel Karl Gottfrid Nyman

  • Stilling:
    Postdoktor
    ved Institutt for nevromedisin og bevegelsesvitenskap ved Norges teknisk-naturvitenskapelige universitet

Klassifisering

Emneord

Medical Imaging • Nyfødtmedisin • Neurovitenskap / nevrovitenskap • Rottehjerne • Mikrodialyse • Stamcelleforskning • MR • Translasjonell medisinsk forskning

Resultater Resultater

Investigation of Metabolism in Cerebral Organoids Derived from Patients with Preclinical Alzheimer's Disease.

Johannessen, Fredrik Røkke; Andreassen, Trygve; Scheffler, Katja; Nyman, Axel Karl Gottfrid. 2023, Frampeik. NTNUVitenskapelig foredrag

Development of a Translational Metabolic Platform for Brain Disorders, Exemplified by Preclinical Alzheimer's Disease.

Johannessen, Fredrik Røkke; Andreassen, Trygve; Scheffler, Katja; Nyman, Axel Karl Gottfrid. 2024, 4th Nordic Neuroscience Meeting. NTNUPoster

In vitro and in vivo evaluation of organic solvent-free injectable melatonin nanoformulations.

Molska, Alicja; Nyman, Axel Karl Gottfrid; Sofias, Alexandros Marios; Kristiansen, Kåre Andre; Hak, Sjoerd; Widerøe, Marius. 2020, European journal of pharmaceutics and biopharmaceutics. SINTEF, NTNU, RTHAVitenskapelig artikkel

Transient effect of melatonin treatment after neonatal hypoxic-ischemic brain injury in rats.

Berger, Hester Rijkje; Nyman, Axel Karl Gottfrid; Morken, Tora Sund; Widerøe, Marius. 2019, PLOS ONE. STOLAV, NTNUVitenskapelig artikkel

Melatonin treatment for hypoxic-ischemic brain injury. Lipid-based nanoparticles as a platform for drug delivery.

Molska, Alicja; Sofias, Alexandros Marios; Nyman, Axel Karl Gottfrid; Hak, Sjoerd; Widerøe, Marius. 2017, The 5th National PhD Conference in Neuroscience. NTNUFaglig foredrag
1 - 5 av 26 | Neste | Siste »

Utmerkelser

  • 2013 - Best blitz presentation, NRSN PhD Conference.